JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment

Annals of Neurology

Volumn 74, Issue 4, 2013, Pages 622-626

  Schippling, Sven ^a   Kempf, Christian ^b   Büchele, Fabian ^a   Jelcic, Ivan ^a   Bozinov, Oliver ^c   Bont, Adriano ^d   Linnebank, Michael ^a   Sospedra, Mireia ^a   Weller, Michael ^a   Budka, Herbert ^b   Martin, Roland ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d Private Clinic   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NATALIZUMAB;

ADULT; ARTICLE; BRAIN BIOPSY; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CEREBELLUM; CEREBELLUM ATROPHY; CLINICAL FEATURE; DRUG SAFETY; FEMALE; GRANULE CELL NEURONOPATHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOHISTOCHEMISTRY; JC VIRUS; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NEURORADIOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIGENS, CD; BRAIN; FEMALE; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; SPINOCEREBELLAR DEGENERATIONS;

EID: 84890122301     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23973     Document Type: Article

References (21)

1. Padgett BL, Walker DL, ZuRhein GM, et al. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971; 1: 1257-1260.
2. Major EO,. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Ann Rev Med 2010; 61: 35-47.
3. Tan CS, Koralnik IJ,. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 2010; 9: 425-437.
4. Kleinschmidt-DeMasters BK, Tyler KL,. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 2005; 353: 369-374.
5. Clifford DB, Ances B, Costello C, et al. Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Arch Neurol 2011; 68: 1156-1164.
6. Kothary N, Diak IL, Brinker A, et al. Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients. J Am Acad Dermatol 2011; 65: 546-551.
7. Biogen Idec. Tysabri update/physician information. Available at: http://biogenidec.com Accessed January 14, 2013.
8. Egli A, Infanti L, Dumoulin A, et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 2009; 199: 837-846.
9. Vermersch P, Kappos L, Gold R, et al. Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy. Neurology 2011; 76: 1697-1704.
10. Cinque P, Koralnik IJ, Gerevini S, et al. Progressive multifocal leukoencephalopathy in HIV-1 infection. Lancet Infect Dis 2009; 9: 625-636.
11. Tan K, Roda R, Ostrow L, et al. PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. Neurology 2009; 72: 1458-1464.
12. Du Pasquier RA, Corey S, Margolin DH, et al. Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual. Neurology 2003; 61: 775-782.
13. Koralnik IJ, Wüthrich C, Dang X, et al. JC virus granule cell neuronopathy: a novel clinical syndrome distinct from progressive multifocal leukoencephalopathy. Ann Neurol 2005; 57: 576-580.
14. Dang X, Vidal JE, Oliveira AC, et al. JC virus granule cell neuronopathy is associated with VP1 C terminus mutants. J Gen Virol 2012; 93: 175-183.
15. Gheuens S, Wüthrich C, Koralnik IJ,. Progressive multifocal leukoencephalopathy: why gray and white matter. Annu Rev Pathol 2013; 24; 8: 189-215.
16. Wüthrich C, Cheng YM, Joseph JT, et al. Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathy. J Neuropathol Exp Neurol 2009; 68: 15-25.
17. Clifford DB, De Luca A, Simpson DM, et al. Natalizumab associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol 2010; 9: 438-446.
18. Metz I, Radue EW, Oterino A, et al. Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy. Acta Neuropathol 2012; 123: 235-245.
19. Barber DL, Andrade BB, Sereti I, Sher A,. Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none. Nat Rev Microbiol 2012; 10: 150-156.
20. Shelburne SA, Visnegarwala F, Darcourt J, et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 2005; 19: 399-406.
21. Kleinschmidt-DeMasters BK, Miravalle A, Schowinsky J, et al. Update onPML and PML-IRIS occurring in multiple sclerosis patients treated with natalizumab. Neuropathol Exp Neurol 2012; 71: 604-617.